Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Splenic involvement in rheumatic diseases

D Fishman1, D A Isenberg

  • 1Bloomsbury Rheumatology Unit, Department of Medicine, University College London Medical School, England.

Seminars in Arthritis and Rheumatism
|February 7, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.

Lupus·2013
Same author

Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus--report of 17 cases and review of the literature.

Lupus·2013
Same author

Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry's disease.

Lupus·2013
Same author

Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study.

Lupus·2013
Same author

Rheumatological manifestations occurring in patients with diabetes mellitus.

Scandinavian journal of rheumatology·2012
Same author

What constitutes uncertainty in systemic lupus erythematosus and rheumatoid arthritis?

Psychology & health·2012
Same journal

Optimizing the use of patient-reported outcome measures in axial spondyloarthritis: a mixed-methods study from the QUESTIONAX Project.

Seminars in arthritis and rheumatism·2026
Same journal

Barriers and enablers to the implementation of osteoarthritis management programmes in primary or community care settings: A systematic review and qualitative framework synthesis.

Seminars in arthritis and rheumatism·2026
Same journal

Predictors of relapse, early escalation and 1-Year use of glucocorticoids in new-onset polymyalgia rheumatica: A prospective cohort study.

Seminars in arthritis and rheumatism·2026
Same journal

Postoperative complications and outcomes after surgical treatment for tophaceous gout: A systematic review and meta-analysis.

Seminars in arthritis and rheumatism·2026
Same journal

Autoantibody associations in patients with early diffuse cutaneous systemic sclerosis: the prospective registry of early systemic sclerosis.

Seminars in arthritis and rheumatism·2026
Same journal

Effectiveness and safety of primary thromboprophylaxis in antiphospholipid antibody carriers by serological 2023 ACR/EULAR domains.

Seminars in arthritis and rheumatism·2026
See all related articles

Rheumatic diseases like rheumatoid arthritis and lupus can cause serious spleen complications, including rupture and infection. Prompt recognition of these splenic issues is crucial for patient outcomes.

Area of Science:

  • Rheumatology
  • Immunology
  • Pathology

Background:

  • The spleen plays a role in immune function and can be affected by rheumatic diseases.
  • Splenic involvement in rheumatic conditions can lead to significant morbidity and mortality.

Purpose of the Study:

  • To review reported cases of splenic involvement in major rheumatic diseases.
  • To identify rheumatic conditions associated with life-threatening splenic complications.

Main Methods:

  • Comprehensive literature search of Medline database (1966-1997) for spleen and rheumatic disease-related English entries.
  • Review of original articles from bibliographies and major rheumatology textbooks.

Main Results:

  • Rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and polyarteritis nodosa (PAN) patients risk splenic rupture.

Related Experiment Videos

  • Splenomegaly is common in RA (including Felty's syndrome) and SLE; massive splenomegaly is specific to SLE.
  • Abnormal splenic function, infarction, atrophy, and increased infection risk (especially with encapsulated organisms) occur in RA, SLE, Wegener's granulomatosis, and PAN.

    • Conclusions:

    • Serious, potentially fatal splenic complications are observed in various rheumatic diseases.
    • Early identification of splenic complications in rheumatic disease patients is essential for timely management.